169 related articles for article (PubMed ID: 25362531)
1. Membrane steroid receptor-mediated action of soy isoflavones: tip of the iceberg.
Ajdžanović V; Medigović I; Živanović J; Mojić M; Milošević V
J Membr Biol; 2015 Feb; 248(1):1-6. PubMed ID: 25362531
[TBL] [Abstract][Full Text] [Related]
2. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
3. Dual effects of daidzein, a soy isoflavone, on catecholamine synthesis and secretion in cultured bovine adrenal medullary cells.
Liu M; Yanagihara N; Toyohira Y; Tsutsui M; Ueno S; Shinohara Y
Endocrinology; 2007 Nov; 148(11):5348-54. PubMed ID: 17717056
[TBL] [Abstract][Full Text] [Related]
4. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
McCarty MF
Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
[TBL] [Abstract][Full Text] [Related]
5. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
[TBL] [Abstract][Full Text] [Related]
6. Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones.
Ajdžanović V; Mojić M; Maksimović-Ivanić D; Bulatović M; Mijatović S; Milošević V; Spasojević I
J Membr Biol; 2013 Apr; 246(4):307-14. PubMed ID: 23417033
[TBL] [Abstract][Full Text] [Related]
7. Genistein and daidzein decrease food intake and body weight gain in mice, and alter LXR signaling in vivo and in vitro.
Luo T; Miranda-Garcia O; Sasaki G; Wang J; Shay NF
Food Funct; 2018 Dec; 9(12):6257-6267. PubMed ID: 30402623
[TBL] [Abstract][Full Text] [Related]
8. Chlorination and nitration of soy isoflavones.
Boersma BJ; Patel RP; Kirk M; Jackson PL; Muccio D; Darley-Usmar VM; Barnes S
Arch Biochem Biophys; 1999 Aug; 368(2):265-75. PubMed ID: 10441377
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Soy Isoflavones on Steroid Metabolism.
Swart AC; Johannes ID; Sathyapalan T; Atkin SL
Front Endocrinol (Lausanne); 2019; 10():229. PubMed ID: 31031706
[No Abstract] [Full Text] [Related]
10. Metabolism of the soy isoflavones daidzein and genistein by fungi used in the preparation of various fermented soybean foods.
Chang TS; Ding HY; Tai SS; Wu CY
Biosci Biotechnol Biochem; 2007 May; 71(5):1330-3. PubMed ID: 17485838
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of soy-isoflavones in cardiovascular disease. Identification of molecular targets.
Wenzel U; Fuchs D; Daniel H
Hamostaseologie; 2008 Feb; 28(1-2):85-8. PubMed ID: 18278168
[TBL] [Abstract][Full Text] [Related]
12. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
Raschke M; Wähälä K; Pool-Zobel BL
Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
Szliszka E; Krol W
Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
[TBL] [Abstract][Full Text] [Related]
14. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
[TBL] [Abstract][Full Text] [Related]
15. Understanding the cardiovascular actions of soy isoflavones: potential novel targets for antihypertensive drug development.
Martin D; Song J; Mark C; Eyster K
Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):297-312. PubMed ID: 19202595
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity.
Atherton KM; Mutch E; Ford D
Biochem Pharmacol; 2006 Aug; 72(5):624-31. PubMed ID: 16814747
[TBL] [Abstract][Full Text] [Related]
17. The effects of soy isoflavones on obesity.
Ørgaard A; Jensen L
Exp Biol Med (Maywood); 2008 Sep; 233(9):1066-80. PubMed ID: 18535167
[TBL] [Abstract][Full Text] [Related]
18. Studies of the in vitro intestinal metabolism of isoflavones aid in the identification of their urinary metabolites.
Heinonen SM; Wähälä K; Liukkonen KH; Aura AM; Poutanen K; Adlercreutz H
J Agric Food Chem; 2004 May; 52(9):2640-6. PubMed ID: 15113171
[TBL] [Abstract][Full Text] [Related]
19. Soy extract has different effects compared with the isolated isoflavones on the proteome of homocysteine-stressed endothelial cells.
Fuchs D; Dirscherl B; Schroot JH; Daniel H; Wenzel U
Mol Nutr Food Res; 2006 Jan; 50(1):58-69. PubMed ID: 16502433
[TBL] [Abstract][Full Text] [Related]
20. Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: a cross-species and sex comparison.
Soukup ST; Helppi J; Müller DR; Zierau O; Watzl B; Vollmer G; Diel P; Bub A; Kulling SE
Arch Toxicol; 2016 Jun; 90(6):1335-47. PubMed ID: 26838042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
